Presented by expert speakers, our webinars will give you advance insight into topics that will be covered at the event.
Can’t make the date? Still register to receive the webinar recording afterwards.
Cell & Gene Therapy Webinar
HIV Cure and Immuno-Oncology: Powered By One Platform
Wednesday 9 October 2019 | 16:00 BST / 11:00 EDT
Presented by Jeff Galvin, Chief Executive Officer, American Gene Technologies™
- The broad view of gene and cell therapy
- Reprogramming the human-computer
- Repurposing cells for positive patient outcomes
Cell & Gene Therapies are being hailed as the major breakthrough for oncology research and proving to have a wide impact on a variety of previously untreatable indications. Cures are now being developed for infectious and rare diseases and monogenic disorders, with biotech and pharma companies looking to ‘reprogram the human computer’ and repurpose cells for positive patient outcomes in a range of therapeutic modalities.
In this webinar, join American Gene Technologies™ founder Jeff Galvin to discuss the pathways to commercial success with the next class of breakthrough medicines.
Jeff Galvin is the CEO and Founder of American Gene Technologies™ (AGT). He earned his BA degree in Economics from Harvard in 1981 and has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies, including one in the medical technology arena that was sold to Varian, the leading maker of linear accelerators used in cancer therapy. Following his startup experience, he retired to become an Angel Investor in real estate and high tech. He came out of retirement to found and fund AGT after meeting Roscoe Brady at NIH.